Sun.Dec 22, 2024

article thumbnail

PBM reform dropped in Congress' funding package

pharmaphorum

Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government

article thumbnail

Cloudbyz Achieves Dual Recognition for CTMS and EDC Solutions in Everest Group’s 2024 PEAK Matrix®

Cloudbyz

Cloudbyz Earns Dual Recognition in Everest Groups 2024 PEAK Matrix for CTMS and EDC Solutions Driving Innovation in Clinical Trial Management Cloudbyz is proud to announce its dual recognition in Everest Groups 2024 PEAK Matrix assessments for both Clinical Trial Management System (CTMS) and Electronic Data Capture (EDC) solutions. This achievement solidifies Cloudbyzs position as a trusted partner in advancing clinical research through cutting-edge, cloud-based technologies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA clears Ionis drug as first therapy for rare disease FCS

pharmaphorum

Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome

article thumbnail

FDA Rewrites Rules of ‘Healthy’ Foods For First Time in 30 Years

AuroBlog - Aurous Healthcare Clinical Trials blog

Avocados made the cut. (coyot/Pixabay) The United States has redefined what qualifies as “healthy” food for the first time in 30 years, striking items like white bread from the list while welcoming nutrient-rich options such as eggs and salmon, officials said Thursday.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Novo Nordisk sheds billions in value on obesity data

pharmaphorum

Novo Nordisk data on obesity candidate CagriSema falls short of expectations, wiping around $94 billion off its market valuation.

article thumbnail

Lifesciences industry envisages continued advancements in genetic research & population genomics in 2025

AuroBlog - Aurous Healthcare Clinical Trials blog

The life sciences sector has witnessed significant transformation driven by advancements in infrastructure, technology, and accessibility. These cover from genetic testing and precision medicine to the growing integration of generative AI in various aspects of healthcare.

Genetics 100